Well, once you adjust for the discount Aspire gets...yes we have probably been raising about $5M/quarter for the past year.
We went from $700K at the start of 2020 and ended 2020 with $14M in the tank. Subtract salaries and trial costs and you're pretty close to that number you cited. We won't know until a couple more 10Qs come out but Leo no doubt would be raising money when the volume is present.
We need cash for a phase 3 and we need cash for other drugs if B-COVID fails. This is why the stock price does not go up.